(NP (NP (NN Costimulation)) (PP (IN of) (NP (JJ peripheral) (NN blood) (NN T) (NN cell) (NN activation))) (PP (IN by) (NP (JJ human) (JJ endothelial) (NNS cells))) (. .))
(S (NP-SBJ (VBD Enhanced) (NN IL-2) (NN transcription)) (VP (VBZ correlates) (PP (IN with) (NP-COOD (NP (VBN increased) (NN c-fos) (NN synthesis)) (CC and) (NP (NP (VBN increased) (NN Fos) (NN content)) (PP (IN of) (NP (NN AP-1))))))) (. .))
(S (NP-SBJ (NP (JJ Endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-))) (VP-COOD (VP (VBP act) (PP (IN as) (NP (NP (NN APC)) (PP (IN for) (NP (VBG resting) (NN PBL))))) (ADVP (FW in) (FW vitro))) (, ,) (CC and) (VP (MD may) (VP (VB have) (NP (JJ important) (NNS roles)) (ADVP (FW in) (FW vivo)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP-COOD (NP (NN allograft) (NN rejection)) (CC and) (NP (VBN delayed) (NN hypersensitivity))))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP-TMP (RB previously)) (VP (VBD reported) (SBAR (IN that) (S (NP-SBJ (JJ human) (JJ umbilical) (NN vein) (NN EC)) (VP (VBP provide) (NP (JJ costimulatory) (NNS signals)) (PP-DTV (TO to) (NP (JJ PHA-stimulated) (NN PBL))) (PP (IN via) (NP-COOD (NP (ADJP (NN CD2:lymphocyte) (JJ function-associated)) (NN Ag-3)) (CC and) (NP (DT an) (JJ unidentified) (NN ligand) (NN pair)))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (QP (CD three-) (TO to) (JJ eight-fold)) (NN enhancement)) (PP (IN of) (NP (NN IL-2) (NN production))))))))))) (. .))
(S (NP-SBJ-31 (NP (DT The) (JJ physiologic) (NN relevance)) (PP (IN of) (NP (DT this) (NN increase)))) (VP (VBD was) (VP (VBN demonstrated) (NP (-NONE- *-31)) (PP (IN by) (NP-LGS (NP (DT the) (JJ proliferative) (NN advantage)) (VP (VBN provided) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN EC))) (PP-DTV (TO to) (NP (NP (NN PBL)) (VP (ADVP (RB suboptimally)) (VBN stimulated) (NP (-NONE- *)) (PP (IN with) (NP (NN mAb) (NN OKT3))))))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP-TMP (RB now)) (VP (VBP report) (SBAR (IN that) (S (NP-SBJ (NN EC) (NN costimulation)) (VP (VBZ causes) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NN IL-2) (NN mRNA)))) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (VBN increased) (NN IL-2) (NN transcription)) (PP (IN in) (NP (NN PBL))))))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB therefore)) (VP (VBD examined) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN EC))) (PP (IN on) (NP (NP (NN T) (NN cell) (JJ nuclear) (NNS factors)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB regulate) (NP (NN IL-2) (NN transcription)))))) (, ,) (PP (VBG including) (NP (NP (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos-two))) (NNS components)) (PP (IN of) (NP-COOD (NP (DT the) (NN transcription) (NN factor) (NN AP-1)) (, ,) (NP (NN NFAT)) (, ,) (CC and) (NP (NNS others)))))))))) (. .))
(S-COOD (S (NP-SBJ (NN PBL)) (ADVP (RB constitutively)) (VP (VBP express) (NP (NN c-jun) (NNS transcripts)))) (, ,) (CC and) (S (NP-SBJ-33 (NP (DT the) (NN level)) (PP (IN of) (NP (NN c-jun) (NN mRNA)))) (VP (VBZ is) (RB not) (VP (VBN altered) (NP (-NONE- *-33)) (PP (IN by) (NP-LGS (NN PHA) (NN activation))) (PP (IN in) (NP (NP (DT the) (NP-COOD (NP (NN absence)) (CC or) (NP (NN presence)))) (PP (IN of) (NP (NN EC)))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-34 (NN c-fos) (NN mRNA)) (VP-COOD (VP (VBZ is) (ADJP-PRD (JJ absent) (PP (IN from) (NP (VBG resting) (NN T) (NNS cells))))) (CC and) (VP (VBZ is) (VP (VBN induced) (NP (-NONE- *-34)) (PP-TMP (IN on) (NP (NN PHA) (NN activation)))))) (. .))
(S (NP-SBJ (NP (NN EC)) (ADVP (RB alone))) (VP-COOD (VP (VBP do) (RB not) (VP (VB induce) (NP (NN c-fos) (NN mRNA)))) (CC but) (VP (VBP augment) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN c-fos) (NN mRNA))) (PP (IN in) (NP (JJ PHA-activated) (NN T) (NNS cells)))) (PP (IN by) (NP (CD 3-) (TO to) (RB 10-fold))))) (. .))
(S (NP-SBJ (DT This) (NN effect)) (VP (VBZ is) (ADJP-PRD (RB largely) (JJ independent) (PP (IN of) (NP (DT the) (ADJP (NN CD2:lymphocyte) (JJ function-associated)) (NN Ag-3) (NN pathway))))) (. .))
(S (NP-SBJ (NN Gel-shift) (NN analysis)) (VP (VBZ reveals) (NP (NP (DT the) (JJ constitutive) (NN presence)) (PP (IN of) (NP (NP (JJ nuclear) (NNS factors)) (SBAR (-NONE- *ICH*-101)))) (PP (IN in) (NP (VBG resting) (NN PBL))) (SBAR-COOD-101 (SBAR (WHNP-35 (WDT that)) (S (NP-SBJ (-NONE- *T*-35)) (VP (VBP bind) (PP (TO to) (NP (NP (DT the) (JJ proximal) (NN AP-1) (NN site)) (PP (IN of) (NP (DT the) (NN IL-2) (NN promoter)))))))) (CC and) (SBAR (WHNP-36 (IN that)) (S (NP-SBJ (-NONE- *T*-36)) (VP (VBP contain) (NP (JJ immunoreactive) (NP-COOD (NP (NN c-Jun)) (CONJP (CC but) (RB not)) (NP (NN c-Fos))) (NN protein)))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN AP-1)) (PP (IN from) (NP (JJ PHA-activated) (NNS cells)))) (VP (VBZ contains) (NP-COOD (NP (NN c-Jun)) (CC and) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN c-Fos)))))) (. .))
(S (ADVP (RB Strikingly)) (, ,) (NP-SBJ (NP (NN costimulation)) (PP (IN with) (NP (NN EC)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT a) (JJ dramatic) (NN increase)) (PRN (-LRB- -LRB-) (NP (QP (NN up) (TO to) (JJ 15-fold))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NN c-Fos) (NN content)) (PP (IN of) (NP (NN AP-1)))))))) (. .))
(S (NP-SBJ-37 (NP (NNS Levels)) (PP (IN of) (NP (NP (JJ other) (JJ nuclear) (NNS factors)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NN IL-2) (NN regulation))))))) (VP (VBD were) (RB not) (VP (VBN altered) (NP (-NONE- *-37)) (PP (IN by) (NP-LGS (NN EC))) (, ,) (SBAR (IN although) (S (NP-SBJ (NN NFAT-DNA) (NNS complexes)) (VP (VBD migrated) (PP (IN at) (NP (DT a) (ADJP (RB slightly) (JJ different)) (NN mobility)))))))) (. .))
(S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN composition)) (PP (IN of) (NP (NN transcription) (NN factor) (NN AP-1)))))) (VP-COOD (VP (VBZ is) (NP-PRD (NP (DT a) (JJ key) (JJ molecular) (NN mechanism)) (PP (IN for) (NP (VBG increasing) (NN IL-2) (NN transcription))))) (CC and) (VP (MD may) (VP (VB underlie) (NP (NP (DT the) (NN phenomenon)) (PP (IN of) (NP (NP (NN costimulation)) (PP (IN by) (NP (NN EC)))))))))))) (. .))
